Skip to main content
SpringerLink
Log in

Insulin degludec switch cost effective in T1DM in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • EVANS M, et al. Assessing Clinical Benefits and Cost-Effectiveness of Insulin Degludec in Routine Clinical Practice. 74th Annual Scientific Sessions of the American Diabetes Association : abstr. 1179-P, 13 Jun 2014.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Insulin degludec switch cost effective in T1DM in the UK. PharmacoEcon Outcomes News 709, 6 (2014). https://doi.org/10.1007/s40274-014-1457-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1457-z

Search

Navigation